Market Place
Sourcing Support
DC appeals court dismisses FTC case against Endo and Impax`s opioid agreement
28 Aug 2023 //
ENDPTS
Impax`s Generic Colesevelam Hydrochloride Receives Approval in the U.S.
18 Jan 2023 //
FDA
Impax Inks $145M Deal With Direct Purchasers In Opana MDL
20 Jul 2022 //
LAW360
Endo, Impax Beat Bid for Special Procedures at Antitrust Trial
23 Apr 2022 //
BLOOMBERGLAW
Vanda Pharmaceuticals Settles HETLIOZ® Patent Litigation with MSN
14 Jan 2022 //
PRNEWSWIRE
Labaton Sucharow & F. Kanner London & Millen Announce Pendency of Class Action
07 Oct 2021 //
PRNEWSWIRE
Fifth Circuit sides with FTC in major pay-for-delay settlement case
15 Apr 2021 //
ENDPTS
FTC Makes Double Reverse Payment Case Against Endo And Impax
02 Feb 2021 //
PHARMAINTELLIGENCE
Impax Lab’s Generic Sevelamer Carbonate Receives Approval In US
25 Nov 2020 //
FDA
Impax Lab’s Generic Teriflunomide Receives Tentative Approval In US
25 Jun 2020 //
FDA
Impax Lab’s Generic Teriflunomide Receives Approval In US
25 Jun 2020 //
FDA
FDA alerts patients and health care professionals of Amneal and Impax Lab
02 Jun 2020 //
FDA
Feds: Impax struck `pay-for-delay` deal with Endo on Opana ER
01 Apr 2019 //
FIERCE PHARMA
Sandoz launches EpiPen rival at $250 per two-pack
18 Jan 2019 //
BIOPHARMA DIVE
Allergan architect Bisaro exits board as revamp continues
30 Aug 2018 //
FIERCE PHARMA
Novartis quietly hands topical treatment for rare disease to LifeMax
27 Aug 2018 //
ENDPTS
FTC Approves Merger of Generic Drug Marketers Amneal, Impax
11 Jul 2018 //
FTC GOV
FTC imposes conditions on Amneal acquisition of Impax
11 Jul 2018 //
PHARMA LETTER
Novartis takes aim at EpiPen with deal for Adamis rival
02 Jul 2018 //
FIERCE PHARMA
In a setback to the FTC, a judge dismisses antitrust allegations Impax Labs
25 May 2018 //
STATNEWS
Impax Lab’s Generic Colesevelam HCl Receives Approval In US
21 May 2018 //
FDA
Amneal Pharma Celebrates Combination by Ringing Opening Bell at NYSE
18 May 2018 //
PRNEWSWIRE
Rytary® (Levodopa/Carbidopa) Capsules: Impax Lab, v. Actavis Laboratories
17 May 2018 //
PATENT LITIGATION
Impax Lab’s Generic Carvedilol Phosphate Receives Approval In US
09 May 2018 //
FDA
ANI Pharmaceuticals Completes Acq.of Generic Products & Assets from Amneal/Impax
07 May 2018 //
PR NEWSWIRE
U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs
01 May 2018 //
REUTERS
ANI Pharma`s Signs Agreements to Acquire Generic Products from Amneal/Impax
27 Apr 2018 //
PR NEWSWIRE
Mydayis®(Amphetamine ): Shire Development v. Impax Laboratories
13 Apr 2018 //
PATENT LITIGATION
Mylan Strengthens with a Successful $1.5 Billion Bond Offering
06 Apr 2018 //
PRNEWSWIRE
Impax reaches $20 million deal to end trial over generic drug`s delay
30 Mar 2018 //
REUTERS
Impax Shareholders Approve Proposed Business Combination with Amneal
27 Mar 2018 //
PR NEWSWIRE
Impax settles retailers` antitrust cases over generic drug`s delay
26 Mar 2018 //
INVESTORS
Impax broke U.S. antitrust law by delaying generic drug, jury told
13 Mar 2018 //
REUTERS
Impax introduces generic Solodyn ER tablets
21 Feb 2018 //
PHARMABIZ
Impax Announces the Launch of an Authorized Generic Version of Solodyn®
20 Feb 2018 //
PR NEWSWIRE
CorePharma to reopen under new ownership following Impax sale
31 Jan 2018 //
OUTSOURCING
Amneal expands NY site ahead of Impax merger
31 Jan 2018 //
IN PHARMATECHNOLOGIST
CorePharma, LLC Acquired by Investor Group
30 Jan 2018 //
PR NEWSWIRE
Impax sells Taiwan plant, strikes Rytary supply deal with Bora Pharmaceuticals
04 Jan 2018 //
FIERCE PHARMA
Chutes & Ladders—Novartis oncology head Strigini to retire
21 Dec 2017 //
FIERCE BIOTECH
Impax Announces Sale of Taiwan Manufacturing Facility
19 Dec 2017 //
PR NEWSWIRE
Bisaro, Amneal poach top Allergan exec for CEO`s chair
19 Dec 2017 //
FIERCE PHARMA
Impax Lab’sGeneric Carvedilol Phosphate Receives Approval In US
10 Dec 2017 //
FDA
Impax Receives Tentative FDA Approval of Generic Coreg CR® Carvedilol Phosphate
09 Dec 2017 //
PR NEWSWIRE
Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly
08 Nov 2017 //
PR NEWSWIRE
Impax Lab’s Generic Sevelamer Carbonate Receives Approval In US
26 Oct 2017 //
FDA
Impax Labs shares rise on FDA approval of generic Renvela
23 Oct 2017 //
MARKETWATCH
Impax Announces FDA Approval and Launch of Generic Renvela Sevelamer Carbonate
23 Oct 2017 //
PR NEWSWIRE
Drugmakers Amneal, Impax to combine in generics push
18 Oct 2017 //
REUTERS
Endo could be the next generics player hunting for M&A: analyst
04 Oct 2017 //
FIERCE PHARMA
Impax CEO Bisaro reportedly putting his M&A moves on Amneal
23 Sep 2017 //
FIERCE PHARMA
Bay Area`s IMPAX Labs (IPXL) Surges on Merger Buzz
22 Sep 2017 //
BIOSPACE
Impax Loses Fees Bid In Opioid Pay-For-Delay Row With FTC
22 Aug 2017 //
LAW360
Impax Announces Settlement of Contract Litigation on Opana® ER Oxymorphone HCL
07 Aug 2017 //
PR NEWSWIRE
As drug prices drop, generics makers fight back with deals
28 Jul 2017 //
REUTERS
Impax Shares Jump on FDA Approval for Generic Version of Concerta
18 Jul 2017 //
THESTREET
Impax Announces FDA Approval of Generic Concerta Methylphenidate HCL
17 Jul 2017 //
PR NEWSWIRE
Impax Lab’s Generic Dexmethylphenidate Hydrochloride Receives Approval In US
06 Jul 2017 //
FDA
Impax Announces FDA Approval of Generic Focalin XR Dexmethylphenidate HCL
05 Jul 2017 //
PR NEWSWIRE
